Multiple endogenous pathways via released growth factors and extracellular matrix components

Multiple endogenous pathways via released growth factors and ECM components refers to a complex therapeutic mechanism rather than a single molecular target. This approach is central to regenerative medicine, where biological products like dehydrated human amnion/chorion membranes or extracellular matrix scaffolds are used to treat non-healing wounds and tissue injuries. These products function by providing a structural framework and a reservoir of bioactive molecules that mimic the natural healing environment. The released growth factors bind to various cell-surface receptors, triggering intracellular cascades that promote angiogenesis, reduce inflammation, and stimulate the recruitment of progenitor cells. Simultaneously, the ECM components provide essential cues for cell adhesion and migration through integrin-mediated signaling. This multifaceted interaction helps to restart the physiological healing process in chronic conditions where endogenous repair mechanisms have failed (Haugh et al., 2017, PubMed; NIH StatPearls on Wound Healing).

Other names

Endogenous regenerative pathwaysECM-mediated signalingGrowth factor-induced tissue repairRegenerative secretome signaling

This mechanism involves the exogenous delivery of a complex biological matrix that releases a variety of growth factors (e.g., VEGF, PDGF, TGF-beta) and extracellular matrix (ECM) proteins (e.g., collagen, fibronectin). These molecules act synergistically to activate multiple endogenous signaling pathways, such as MAPK/ERK and PI3K/Akt, which stimulate resident cells to undergo proliferation, migration, and differentiation, thereby promoting tissue repair and regeneration (Koob et al., 2013, PubMed; Schultz et al., 2011, PubMed).